Reported Jun 7, 2023 · Ongoing
Cetrorelix Acetate for Injection, 0.25 mg, , One carton contains one packaged tray which contains: 1 vial with…
Akorn, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Akorn, Inc. · 5605 Centerpoint Ct Ste A · Gurnee, IL · 60031-5278
Is this the product you have?
- Cetrorelix Acetate for Injection, 0.25 mg, , One carton contains
- one packaged tray which contains1 vial with lyophilized powder for reconstitution, 1 pre-filled syringe with diluent, 1 20-gauge needle, 1 27-gauge needle, Sterile - For subcutaneous use only, Rx Only
- Manufactured byGP Pharm S.A. Barcelona, Spain (ESP) -08777
- Distributed byAkorn Operating Company, LLC., Gurnee, IL 60031. ALL NDCs
- Lot codes and dates
- All Lots
- Amount recalled
- N/A
This recall covers 86 products
The agency filed one notice per product. You are reading one of them; the other 85 are below.
73 more are in the archive.
Where it was sold
- Nationwide
- PR
Why it was recalled
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Akorn, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.